[go: up one dir, main page]

CO6260101A2 - Nuevos genes y proteinas de branchyspira hyodysenteriae y el uso de los mismos - Google Patents

Nuevos genes y proteinas de branchyspira hyodysenteriae y el uso de los mismos

Info

Publication number
CO6260101A2
CO6260101A2 CO10024772A CO10024772A CO6260101A2 CO 6260101 A2 CO6260101 A2 CO 6260101A2 CO 10024772 A CO10024772 A CO 10024772A CO 10024772 A CO10024772 A CO 10024772A CO 6260101 A2 CO6260101 A2 CO 6260101A2
Authority
CO
Colombia
Prior art keywords
plasmid
hyodysenteriae
polynucleotide
brachyspira
useful
Prior art date
Application number
CO10024772A
Other languages
English (en)
Inventor
Matthew Bellgard
David John Hampson
Tom La
Original Assignee
Spirogene Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Spirogene Pty Ltd filed Critical Spirogene Pty Ltd
Publication of CO6260101A2 publication Critical patent/CO6260101A2/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/20—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0225—Spirochetes, e.g. Treponema, Leptospira, Borrelia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/20—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Se describen el nuevo Polinucleótido y los aminoácidos de Brachyspira hyodysenteriae. Estas secuencias son útiles para el diagnóstico de la enfermedad de B. hyodysenteriae en animales y útiles como un tratamiento terapéutico o profiláctico de la enfermedad de B. hyodysenteriae en animales. Estas secuencias pueden también ser útiles para el diagnóstico y para el tratamiento terapéutico y/o profiláctico de enfermedades de los animales causada por Brachyspira en otras especies, incluyendo B. intermedia, B. suantatina, B.alvinipulli B. aalborgi, B.lnnocens, B.murdochii, y B. pilosicoli. 1.- Un polinucleótido que comprende la secuencia seleccionada del grupo que consiste de SEQ ID NO: 1, 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43, 45, 47, 49, 51, 53, 55, 57, 59, 61, 63 y 65. 2.- Un plásmido que comprende el polinucleótido de la reivindicación 1. 3.- El plásmido de la reivindicación 2 en donde dicho plásmido es un vector de expresión. 4.- Una célula que contiene el plásmido de la reivindicación 2. 5.- Una célula que contiene el plásmido de la reivindicación 3. 6.- Una composición inmunogénica que comprende el plásmido de la reivindicación 3. 7.- La composición de la vacuna para el tratamiento o la prevención de Brachyspira hyodysenteriae que comprende el vector de expresión de la reivindicación 3. 8.- La composición de la vacuna para el tratamiento o la prevención de Brachyspira hyodysenteriae que comprende la celda de la reivindicación 4. 9.- Una molécula de ADN que comprende una secuencia que es al menos 70% idéntica a la de los polinucleótidos de la reivindicación 1. 10.- Un plásmido que comprende el polinucleótido de la reivindicación 9.
CO10024772A 2007-08-03 2010-03-03 Nuevos genes y proteinas de branchyspira hyodysenteriae y el uso de los mismos CO6260101A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2007/058049 WO2008017636A2 (en) 2006-08-09 2007-08-03 Genes and proteins of brachyspira hyodysenteriae and uses thereof

Publications (1)

Publication Number Publication Date
CO6260101A2 true CO6260101A2 (es) 2011-03-22

Family

ID=38667160

Family Applications (1)

Application Number Title Priority Date Filing Date
CO10024772A CO6260101A2 (es) 2007-08-03 2010-03-03 Nuevos genes y proteinas de branchyspira hyodysenteriae y el uso de los mismos

Country Status (11)

Country Link
US (2) US8992938B2 (es)
EP (2) EP2185578A2 (es)
JP (1) JP2010535030A (es)
KR (2) KR20100080591A (es)
CN (1) CN101821284B (es)
AU (2) AU2007283667B2 (es)
BR (1) BRPI0721908A2 (es)
CO (1) CO6260101A2 (es)
MX (1) MX2010001381A (es)
UA (1) UA104714C2 (es)
WO (1) WO2008017636A2 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2185578A2 (en) * 2007-08-03 2010-05-19 Spirogene Pty Ltd Genes and proteins of brachyspira hyodysenteriae and uses thereof
EP2363407A1 (en) * 2008-02-28 2011-09-07 Murdoch University Novel sequences of Brachyspira, immunogenic compositions, methods for preparation and use thereof
AU2009227986C1 (en) * 2008-03-27 2014-06-19 Murdoch University Novel sequences of Brachyspira, immunogenic compositions, methods for preparation and use thereof
US9695221B2 (en) 2012-12-21 2017-07-04 Boehringer Ingelheim Vetmedica Gmbh Recombinant outer membrane proteins from Brachyspira hyodysenteriae and uses thereof
US10188715B2 (en) 2013-06-28 2019-01-29 Aquilon Cyl Sociedad Limitada Swine dysentery vaccine
CN112479189B (zh) * 2014-02-17 2024-07-09 威廉马歇莱思大学 激光诱导的石墨烯材料和它们在电子装置中的用途
RU2018127200A (ru) * 2016-01-07 2020-02-07 Университейт Гент Вакцинные штаммы brachyspira hyodysenteriae

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3654090A (en) 1968-09-24 1972-04-04 Organon Method for the determination of antigens and antibodies
USRE31006E (en) 1968-09-24 1982-08-03 Akzona Incorporated Process for the demonstration and determination of reaction components having specific binding affinity for each other
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
US4016043A (en) 1975-09-04 1977-04-05 Akzona Incorporated Enzymatic immunological method for the determination of antigens and antibodies
US4491632A (en) 1979-10-22 1985-01-01 The Massachusetts General Hospital Process for producing antibodies to hepatitis virus and cell lines therefor
US4444887A (en) 1979-12-10 1984-04-24 Sloan-Kettering Institute Process for making human antibody producing B-lymphocytes
US4342566A (en) 1980-02-22 1982-08-03 Scripps Clinic & Research Foundation Solid phase anti-C3 assay for detection of immune complexes
EP0043718B1 (en) 1980-07-07 1984-11-28 National Research Development Corporation Improvements in or relating to cell lines
US4341761A (en) 1980-07-25 1982-07-27 E. I. Du Pont De Nemours And Company Antibodies to immunogenic peptides and their use to purify human fibroblast interferon
US4466917A (en) 1981-02-12 1984-08-21 New York University Malaria vaccine
US4493890A (en) 1981-03-23 1985-01-15 Miles Laboratories, Inc. Activated apoglucose oxidase and its use in specific binding assays
US4451570A (en) 1981-03-26 1984-05-29 The Regents Of The University Of California Immunoglobulin-secreting human hybridomas from a cultured human lymphoblastoid cell line
US4399121A (en) 1981-11-04 1983-08-16 Miles Laboratories, Inc. Iodothyronine immunogens and antibodies
US4427783A (en) 1981-12-14 1984-01-24 Hoffmann-La Roche Inc. Immunoassay of thymosin α1
GB8308235D0 (en) 1983-03-25 1983-05-05 Celltech Ltd Polypeptides
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
CA1319101C (en) 1986-09-03 1993-06-15 Marta Iris Sabara Rotavirus nucleocapsid protein with or without binding peptides as immunologic carriers for macromolecules
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
US6673776B1 (en) 1989-03-21 2004-01-06 Vical Incorporated Expression of exogenous polynucleotide sequences in a vertebrate, mammal, fish, bird or human
JPH05502370A (ja) * 1989-09-13 1993-04-28 エムエル　テクノロジー　ヴェンチャーズ　エル．ピー． 分子量３９ｋＤａの赤痢病原体抗原およびそれに対する遺伝子暗号付与
ZA918426B (en) 1990-10-31 1992-12-30 Akzo Nv Chicken anemia virus vaccine and diagnostic
EP0486106A3 (en) 1990-11-16 1992-12-23 Akzo N.V. Marek's disease virus vaccine
US5612487A (en) 1991-08-26 1997-03-18 Edible Vaccines, Inc. Anti-viral vaccines expressed in plants
US6034298A (en) 1991-08-26 2000-03-07 Prodigene, Inc. Vaccines expressed in plants
US5837832A (en) 1993-06-25 1998-11-17 Affymetrix, Inc. Arrays of nucleic acid probes on biological chips
US5712118A (en) 1993-09-29 1998-01-27 Research Foundation Of State University Of New York Vaccine for branhamella catarrhalis
US6682729B1 (en) 1995-05-03 2004-01-27 University Of Maryland, Baltimore Method for introducing and expressing genes in animal cells, and live invasive bacterial vectors for use in the same
US5877159A (en) 1995-05-03 1999-03-02 University Of Maryland At Baltimore Method for introducing and expressing genes in animal cells and live invasive bacterial vectors for use in the same
US6150170A (en) 1998-05-03 2000-11-21 University Of Maryland At Baltimore Method for introducing and expressing genes in animal cells, and live invasive bacterial vectors for use in the same
US5824538A (en) 1995-09-06 1998-10-20 The United States Of America As Represented By The Secretary Of The Army Shigella vector for delivering DNA to a mammalian cell
WO1999018221A1 (en) 1997-10-07 1999-04-15 University Of Maryland Biotechnology Institute Method for introducing and expressing rna in animal cells
WO2001023537A1 (en) 1999-09-24 2001-04-05 Cyto Pulse Sciences, Inc. Process for enhancing electric field-mediated delivery of biological materials into cells
WO2001066138A2 (en) 2000-03-07 2001-09-13 U.S. Army Medical Research Institute Of Infectious Diseases Dna vaccines against poxviruses
AU2001250859A1 (en) 2000-03-16 2001-09-24 Joseph J. Drabick Method for gene transfection and vaccination through skin using electropermeabilization
JP2006500914A (ja) * 2002-05-08 2006-01-12 アクゾ・ノベル・エヌ・ベー ブタ赤痢（Ｂｒａｃｈｙｓｐｉｒａｈｙｏｄｙｓｅｎｔｅｒｉａｅ）ワクチン
JP2005532804A (ja) * 2002-07-17 2005-11-04 アクゾ・ノベル・エヌ・ベー ブラキスピラ・ヒオジセンテリアエワクチン
AU2002953431A0 (en) * 2002-12-19 2003-01-09 Murdoch University BmpB Novel Nucleotide and Amino Acid Sequences and Diagnostic and Therapeutic Uses Thereof
CN1898385A (zh) * 2003-12-19 2007-01-17 莫道什大学 多毛结肠短螺旋体72kDa外膜蛋白及其诊断和治疗用途
US8834891B2 (en) * 2005-03-14 2014-09-16 Boehringer Ingelheim Vetmedica, Inc. Immunogenic compositions comprising Lawsonia intracellularis
EP1882035A2 (en) * 2005-05-12 2008-01-30 Novartis AG Genes and proteins of brachyspira hyodysenteriae and use of same for diagnosis and therapy
EP2001901A2 (en) * 2006-03-20 2008-12-17 Murdoch University Novel genes and proteins of brachyspira hyodysenteriae and use of same for diagnosis and therapy
EP2185578A2 (en) * 2007-08-03 2010-05-19 Spirogene Pty Ltd Genes and proteins of brachyspira hyodysenteriae and uses thereof
EP2363407A1 (en) * 2008-02-28 2011-09-07 Murdoch University Novel sequences of Brachyspira, immunogenic compositions, methods for preparation and use thereof
AU2009227986C1 (en) * 2008-03-27 2014-06-19 Murdoch University Novel sequences of Brachyspira, immunogenic compositions, methods for preparation and use thereof
JP2012508564A (ja) * 2008-11-14 2012-04-12 ベーリンガー インゲルハイム フェトメディカ ゲーエムベーハー ブラキスピラ・ヒオディセンテリアのワクチン株

Also Published As

Publication number Publication date
US20160052974A1 (en) 2016-02-25
BRPI0721908A2 (pt) 2014-02-25
JP2010535030A (ja) 2010-11-18
KR20140120946A (ko) 2014-10-14
MX2010001381A (es) 2010-09-14
AU2007283667B2 (en) 2014-09-04
CN101821284A (zh) 2010-09-01
AU2007283667A1 (en) 2008-02-14
CN101821284B (zh) 2014-11-19
EP3018139A3 (en) 2016-08-10
WO2008017636A8 (en) 2009-10-01
WO2008017636A2 (en) 2008-02-14
WO2008017636A3 (en) 2008-04-17
KR20100080591A (ko) 2010-07-09
EP3018139A2 (en) 2016-05-11
UA104714C2 (ru) 2014-03-11
US20110020383A1 (en) 2011-01-27
US8992938B2 (en) 2015-03-31
EP2185578A2 (en) 2010-05-19
AU2014213506A1 (en) 2014-09-04

Similar Documents

Publication Publication Date Title
CO6260101A2 (es) Nuevos genes y proteinas de branchyspira hyodysenteriae y el uso de los mismos
CL2020000252A1 (es) Muteínas de interleucina 21 y métodos de tratamiento.
CL2018000537A1 (es) Anticuerpo anti-factor d del complemento; polinucleótido codificante; vector que comprende dicho polinucleótido; célula húesped que comprende dicho vector; método de fabricación de anticuerpo; composición farmacéutica que lo comprende; uso del anticuerpo para tratar trastornos inflamatorios o trastornos oculares (divisional de cl 1001-2009).
AR074397A1 (es) Polipéptidos receptores de activina iib estabilizados y usos de los mismos
BR112015005674A2 (pt) variantes e métodos de uso de hppd
CY1120685T1 (el) Ρετινοειδες-λιποσωματα για ενισχυση ρυθμισης εκφρασης hsp47
AR074871A1 (es) Genes pesticidas de brevibacillus y metodos para su uso
AR049014A1 (es) Mimeticuerpos de glp-1 humanos , composiciones y usos
CO6400155A2 (es) Gen de delta-endotoxina axmi-150 y métodos de uso del mismo
CL2019002167A1 (es) Compuesto de la fórmula (ic) o una sal farmacéuticamente aceptable del mismo, o una composición farmacéutica que comprende dicho compuesto o una sal farmacéuticamente aceptable del mismo, y al menos un portador farmacéuticamente aceptable, y su uso en el tratamiento de disautonomía familiar al mejorar el empalme de marn. (divisional solicitud 201701823.)
PE20241305A1 (es) Analogos de amilina
BRPI0815578B8 (pt) Peptídeo de cdca1, seu uso e composição imunogênica compreendendo o mesmo para induzir imunidade, tratar e/ou prevenir o câncer, bem como método in vitro para induzir uma célula apresentadora de antígeno e uma célula t citotóxica (killer)
WO2015149944A3 (en) Polymeric carrier cargo complex for use as an immunostimulating agent or as an adjuvant
MX2015005328A (es) Composiciones y metodos para la administracion selectiva de moleculas de oligonucleotidos a tipos de celulas.
AR083839A1 (es) Virus del sindrome reproductivo y respiratorio porcino (prrs) de los estados unidos y sus usos
AR080200A1 (es) Genes delta-endotoxinicos axmi221z, axmi222z, axmi223z, axmi224z, y axmi225z y metodos para su uso
AR075818A1 (es) Axmi-001, axmi- 002, axmi-030 y axmi -035 y axmi -045: genes de toxina y metodos para su uso
AR079114A1 (es) Proteinas de enlace de antigenos anti-orai1 y usos de las mismas
BR112014001978A2 (pt) proteínas variantes axmi205 e métodos para a utilização das mesmas
RU2017126566A (ru) ВСТРЕЧАЮЩИЕСЯ В ПРИРОДЕ миРНК ДЛЯ КОНТРОЛИРОВАНИЯ ЭКСПРЕССИИ ГЕНОВ И ИХ ПРИМЕНЕНИЕ
PE20141549A1 (es) VARIANTES DE CRIg MADURAS POR AFINIDAD
AR053385A1 (es) Genes y proteinas novedosos de brachyspira hyodysenteriae y uso de los mismos para diagnostico y terapia
AR069573A1 (es) Promotores de proteinas quimericas y ricas en prolina para la expresion en plantas, donde el fenotipo es una menor infeccion por patogenos
AR053372A1 (es) Proteinas inmunologicas de lawsonia intracellularis
WO2007107323A8 (en) Novel genes and proteins of brachyspira hyodysenteriae and use of same for diagnosis and therapy

Legal Events

Date Code Title Description
FC Application refused